• Nenhum resultado encontrado

Pneumococcal Vaccine

Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital

Theoretical pneumococcal vaccine coverage: analysis of serotypes isolated from inpatients at a tertiary care hospital

... 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine ...yielded pneumococcal isolates. The theoretical vaccine coverage was ...

6

The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014

The impact of pneumococcal vaccine in reducing pneumonia hospitalizations in children under 5 years old, in Santa Catarina, Brazil, 2006 a 2014

... following vaccine implantation available for ...after vaccine implementation is very appropriate for data on the type of ...the vaccine not being ...polysaccharide vaccine and PCV7 ...

9

Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.

Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.

... of pneumococcal vaccine) from a cost-effectiveness study for dengue vaccines in Panama, a middle income country [52], all the vaccination programs considered would be very cost-effective and would provide ...

9

Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine in Elderly Residents of a Long-Term Care Facility

Immunogenicity of a 23-Valent Pneumococcal Polysaccharide Vaccine in Elderly Residents of a Long-Term Care Facility

... 23-valent pneumococcal polysaccharide vaccine and the persistence of antibodies two years after the vaccination in an elderly population in Santiago, ...the pneumococcal or a tetanus control ...The ...

5

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly

... the pneumococcal vaccine agrees with the results of other studies ...to pneumococcal polysaccharide antigens, but that their response is reduced with the ill effects of aging and the increase of ...

10

J. Pediatr. (Rio J.)  vol.81 número1 en v81n1a17a

J. Pediatr. (Rio J.) vol.81 número1 en v81n1a17a

... conjugated pneumococcal vaccines are ...conjugated pneumococcal vaccine, the 7-valent vaccine conjugated with the CRM197 diphtheria toxin (serotypes 4, 6B, 9V, 14, 18C, 19F and 23F), which is ...

1

Progress towards meningitis prevention in the conjugate vaccines era

Progress towards meningitis prevention in the conjugate vaccines era

... conjugate vaccine is a reduction in meningitis cases, the pneumococcal vaccines are also expected to reduce pneumonia and acute otitis media cases, as well as carriage prevalence, which will significantly ...

10

Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.

Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.

... mouse pneumococcal serotype 6B colonization ...against pneumococcal colonization, one or more of these proteins may serve as components of a multivalent pneumococcal ...

7

J. Pediatr. (Rio J.)  vol.88 número1 en a16v88n01

J. Pediatr. (Rio J.) vol.88 número1 en a16v88n01

... with the diagnosis of pneumonia based on ICD-9 classiication— hence, with a clinical, clinician-deined diagnosis. However, there is no mention of the ICD codes used to deine pneumonia in the study (apparently, unqualiied ...

2

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.

... Background. Pneumococcal diseases—illnesses caused by Streptococcus pneumoniae bacteria—are leading causes of illness and death around the ...invasive pneumococcal diseases (IPDs) are often ...from ...

13

Sao Paulo Med. J.  vol.132 número4

Sao Paulo Med. J. vol.132 número4

... zoster vaccine with an active virus has been approved for clinical use among older adults by the Food and Drug Administration and has been tested in large ...

1

Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the national immunization program

Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the national immunization program

... Although the number of isolates included in this analysis is relatively low, our results contribute to overall compre- hension of circulating serotypes of Streptococcus pneu- moniae in Vojvodina region in the ...

6

Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.

Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology.

... 99 pneumococcal isolates represent- ing 29 different serotypes selected randomly from the 528 pneumococcal ...diverse pneumococcal population structure in Nigeria, which is different from those STs ...

9

Scientific Institutions in Latin America : The Butantan Institute

Scientific Institutions in Latin America : The Butantan Institute

... serum and vaccine; pneumonia serum and vaccine; gangrene serum; serum for the treatment of whooping-cough; smallpox vaccine; pyogenic vaccine; streptococcus serum and[r] ...

5

Avaliação da efetividade da vacina antipneumocócica 10 valente na redução da doença pneumocócica invasiva em crianças brasileiras : estudo caso controle multicêntrico

Avaliação da efetividade da vacina antipneumocócica 10 valente na redução da doença pneumocócica invasiva em crianças brasileiras : estudo caso controle multicêntrico

... of pneumococcal conjugate vaccine in national immunization programs has a key role in the prevention of diseases caused by ...of pneumococcal conjugate 10 valent vaccine (PCV-10) against ...

152

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.

... in vaccine arm vs 3 in the placebo arm) ...PCV13 vaccine types due to the herd immunity impact of the 10– valent PCV childhood vaccination programme introduced in the Netherlands in 2011 and which covered ...

14

Rev. paul. pediatr.  vol.34 número4

Rev. paul. pediatr. vol.34 número4

... In analyzing the periods before and after the introduction of PCV-10 in PNI, as shown in Fig. 1, the number of CAP hos- pitalizations in the 26 selected municipalities had shown a decline from 2009 (pre-vaccine ...

7

Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in Brazil

Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in Brazil

... The clinical condition of the volunteers did not present substantial alterations that could be associ- ated significantly with injections of LEISHVACINÒ , and symptoms were reported after injections of pla- cebo in all ...

8

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

... with functional post-booster OPA (S1 Table). Both findings could be a result of carriage of 6A and 19A serotypes by 9–15% of the Dutch children at 11 months [4, 5, 9] or cross-reactivity between serotype 6B and 6A and ...

16

Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?

Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?

... successful vaccine for urogenital schistosomiasis (whether specific only to ...HPV vaccine has been successfully developed and implemented, we may be able to glean important lessons rele- vant to cancer ...

3

Show all 841 documents...

temas relacionados